Role of TLR4 and MAPK in the local effect of LPS on intestinal contractility

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 5, 2011, Pages 657-662

  Barona, Inés ^a   Fagundes, Diego Santos ^a   Gonzalo, Sergio ^a   Grasa, Laura ^a   Arruebo, María Pilar ^a   Plaza, Miguel Ángel ^a   Murillo, María Divina ^a,b  

^a UNIVERSIDAD DE ZARAGOZA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

gastrointestinal motility; K + channels; LPS; MAPK; TLR4

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCHOLINE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; APAMIN; CHARYBDOTOXIN; GLIBENCLAMIDE; IBERIOTOXIN; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; POLYMYXIN; POTASSIUM CHANNEL; QUININE; STRESS ACTIVATED PROTEIN KINASE; TETRYLAMMONIUM CHLORIDE; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUODENUM; IN VITRO STUDY; INCUBATION TIME; INTESTINE CONTRACTION; MALE; NONHUMAN; RABBIT; SMALL INTESTINE; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; THERMOSTABILITY;

ACETYLCHOLINE; ANIMALS; DUODENUM; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE CONTRACTION; MUSCLE, SMOOTH; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RABBITS; TOLL-LIKE RECEPTOR 4;

EID: 79954603154     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01253.x     Document Type: Article

References (44)

1. Hewett JA, Roth RA,. Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 1993; 45: 382-411.
2. Akashi I, et al,. Protective effects of coffee-derived compounds on lipopolysaccharide/d-galactosamine induced acute liver injury in rats. J Pharm Pharmacol 2009; 61: 473-478.
3. Oshima S, et al,. Penetration of oseltamivir and its active metabolite into the brain after lipopolysaccharide-induced inflammation in mice. J Pharm Pharmacol 2009; 61: 1397-1400.
4. Li J, et al,. Penehyclidine prevents nuclear factor-kappaB activation in acute lung injury induced by lipopolysaccharide. J Pharm Pharmacol 2008; 60: 1197-1205.
5. Weisbrodt NW, et al,. Decreased ileal muscle contractility and increased NOS II expression induced by lipopolysaccharide. Am J Physiol 1996; 271: G454-G460.
6. Plaza MA, et al,. Role of central interleukin-1 beta in gastrointestinal motor disturbances induced by lipopolysaccharide in sheep. Dig Dis Sci 1997; 42: 242-250. (Pubitemid 27112965)
7. Eskandari MK, et al,. LPS-induced muscularis macrophage nitric oxide suppresses rat jejunal circular muscle activity. Am J Physiol 1999; 277: G478-G486. (Pubitemid 29415076)
8. Rebollar E, et al,. Effect of lipopolysaccharide on rabbit small intestine muscle contractility in vitro: role of prostaglandins. Neurogastroenterol Motil 2002; 14: 633-642. (Pubitemid 35476899)
9. Hussain S, Delovitch TL,. Dysregulated B7-1 and B7-2 expression on nonobese diabetic mouse B cells is associated with increased T cell costimulation and the development of insulitis. J Immunol 2005; 174: 680-687. (Pubitemid 40094260)
10. Gonzalo S, et al,. Inhibition of p38 MAPK improves intestinal disturbances and oxidative stress induced in a rabbit endotoxemia model. Neurogastroenterol Motil 2010; 22: 564-572, e123.
11. De Filippis D, et al,. Melatonin reverses lipopolysaccharide-induced gastro-intestinal motility disturbances through the inhibition of oxidative stress. J Pineal Res 2008; 44: 45-51. (Pubitemid 350231108)
12. Cohen J,. The immunopathogenesis of sepsis. Nature 2002; 420: 885-891. (Pubitemid 36019643)
13. Tapping RI, et al,. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 2000; 165: 5780-5787.
14. Shin KM, et al,. Bis-(3-hydroxyphenyl) diselenide inhibits LPS-stimulated iNOS and COX-2 expression in RAW 264.7 macrophage cells through the NF-kappaB inactivation. J Pharm Pharmacol 2009; 61: 479-486.
15. Schmid D, et al,. Inhibition of inducible nitric oxide synthesis by Cimicifuga racemosa (Actaea racemosa, black cohosh) extracts in LPS-stimulated RAW 264.7 macrophages. J Pharm Pharmacol 2009; 61: 1089-1096.
16. Pearson G, et al,. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 2001; 22: 153-183. (Pubitemid 32458157)
17. Bradham C, McClay DR,. p38 MAPK in development and cancer. Cell Cycle 2006; 5: 824-828. (Pubitemid 44145574)
18. Waetzig GH, et al,. p38 mitogen-activated protein kinase is activated and linked to TNF-alpha signaling in inflammatory bowel disease. J Immunol 2002; 168: 5342-5351. (Pubitemid 34496003)
19. Scaldaferri F, et al,. The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease. Eur J Immunol 2009; 39: 290-300.
20. Gonzalo S, et al,. Extracellular signal-regulated kinase (ERK) is involved in LPS-induced disturbances in intestinal motility. Neurogastroenterol Motil 2011; 23: e80-e90.
21. Vogalis F,. Potassium channels in gastrointestinal smooth muscle. J Auton Pharmacol 2000; 20: 207-219. (Pubitemid 34209003)
22. Lamarca V, et al,. K+ channels involved in contractility of rabbit small intestine. J Physiol Biochem 2006; 62: 227-236. (Pubitemid 46938951)
23. Grasa L, et al,. The role of tyrosine kinase in prostaglandin E2 and vanadate-evoked contractions in rabbit duodenum in vitro. J Physiol Pharmacol 2006; 57: 279-289. (Pubitemid 44077751)
24. Fagundes DS, et al,. Ca2+-activated K+ channels involved in duodenal dismotility induced by ethanol. Alcohol Alcohol 2007; 42: 291-295.
25. Jerala R,. Structural biology of the LPS recognition. Int J Med Microbiol 2007; 297: 353-363. (Pubitemid 47188054)
26. Turler A, et al,. Endogenous endotoxin participates in causing a panenteric inflammatory ileus after colonic surgery. Ann Surg 2007; 245: 734-744. (Pubitemid 46684103)
27. Hoshino K, et al,. Cutting edge: toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999; 162: 3749-3752. (Pubitemid 29314747)
28. Rumio C, et al,. Activation of smooth muscle and myenteric plexus cells of jejunum via Toll-like receptor 4. J Cell Physiol 2006; 208: 47-54. (Pubitemid 43848988)
29. Venkova K, et al,. Effect of TZP-201, a novel motilin receptor antagonist, in the colon of the musk shrew (Suncus murinus). J Pharm Pharmacol 2009; 61: 367-373.
30. Seydel U, et al,. A K+ channel is involved in LPS signaling. J Endotoxin Res 2001; 7: 243-247.
31. Guo L, et al,. [Influence of lipopolysaccharide and burn sera on ion channels in smooth muscle cells of colon of guinea pig]. Zhonghua Shao Shang Za Zhi 2006; 22: 184-186.
32. Maruyama N, et al,. Quinine inhibits production of tumor necrosis factor-alpha from human alveolar macrophages. Am J Respir Cell Mol Biol 1994; 10: 514-520.
33. McKinney LC, Gallin EK,. Effect of adherence, cell morphology, and lipopolysaccharide on potassium conductance and passive membrane properties of murine macrophage J774.1 cells. J Membr Biol 1990; 116: 47-56. (Pubitemid 20182428)
34. Hoang LM, et al,. Lipopolysaccharide rapidly activates K+ channels at the intracellular membrane face of rat cerebral artery smooth muscle cells. Neurosci Lett 1997; 231: 25-28. (Pubitemid 27366280)
35. Chen SJ, et al,. Abnormal activation of K(+) channels in aortic smooth muscle of rats with endotoxic shock: electrophysiological and functional evidence. Br J Pharmacol 2000; 131: 213-222.
36. Blunck R, et al,. New insights into endotoxin-induced activation of macrophages: involvement of a K+ channel in transmembrane signaling. J Immunol 2001; 166: 1009-1015. (Pubitemid 32060258)
37. Shen KP, et al,. Eugenosedin-A amelioration of lipopolysaccharide-induced up-regulation of p38 MAPK, inducible nitric oxide synthase and cyclooxygenase-2. J Pharm Pharmacol 2007; 59: 879-889.
38. Lee HJ, et al,. Eutigoside C inhibits the production of inflammatory mediators (NO, PGE(2), IL-6) by down-regulating NF-kappaB and MAP kinase activity in LPS-stimulated RAW 264.7 cells. J Pharm Pharmacol 2008; 60: 917-924.
39. Kyriakis JM, Avruch J,. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81: 807-869. (Pubitemid 32267078)
40. Gan HT, et al,. Blockade of p38 mitogen-activated protein kinase pathway ameliorates delayed intestinal transit in burned rats. Am J Surg 2007; 193: 530-537. (Pubitemid 46412252)
41. Capasso R, et al,. Inhibitory effect of quercetin on rat trachea contractility in vitro. J Pharm Pharmacol 2009; 61: 115-119.
42. Wehner S, et al,. Inhibition of p38 mitogen-activated protein kinase pathway as prophylaxis of postoperative ileus in mice. Gastroenterology 2009; 136: 619-629.
43. Grasa L, et al,. A downregulation of nNOS is associated to dysmotility evoked by lipopolysaccharide in rabbit duodenum. J Physiol Pharmacol 2008; 59: 511-524.
44. Gonzalo S, et al,. Intestinal effects of lipopolysaccharide in rabbit are mediated by cyclooxygenase-2 through p38 mitogen activated protein kinase. Eur J Pharmacol 2010; 648: 171-178.